Why the study?
The study was conducted to evaluate the impact of introducing a new pulmonary embolism diagnostic guideline with an elevated D-dimer threshold.
Does raising the D-dimer threshold to 1000 ng/mL reduce imaging rates without increasing missed PE in patients investigated for pulmonary embolism?
Does raising the D-dimer threshold to 1000 ng/mL reduce imaging rates without increasing missed PE in patients investigated for pulmonary embolism?
Raising the D-dimer threshold to 1000 ng/mL for patients with a low Wells' score safely reduced definitive chest imaging rates without increasing missed pulmonary embolism.
Raising D-dimer threshold may reduce imaging; leaves open need for prospective validation before practice change.
OBJECTIVE: The objective of this study was to assess the impact of introduction of a new pulmonary embolism (PE) diagnostic guideline with a raised D-dimer threshold. METHODS: This is a single-site, observational, cohort study with a historical comparison. The new guideline raised the D-dimer threshold to 1000 ng/mL for most patients with a Wells' score of 4 or less. Patients investigated for PE with a D-dimer level and/or definitive imaging in 6-month periods before and after the introduction of the guideline were eligible. Patients with D-dimers of 500-1000 ng/mL were prospectively followed up at 3 months for missed PE. RESULTS: During the pre-intervention period, 688 patients were investigated for PE, 366 (53.2%) received definitive imaging and 39 PE were diagnosed (5.7% overall, 10.7% of those imaged). For the 121 patients with D-dimers ≥500 and <1000 ng/mL, 87 (71.9%) were imaged with 7 (5.8%) having a PE diagnosed. Post intervention there were 930 patients, of which 426 (45.8%) received definitive chest imaging and there were 50 patients with PE diagnosed (5.4% overall, 11.7% of those imaged). For the 185 patients with D-dimers ≥500 and <1000 ng/mL, 60 (32.4%) were imaged with 5 (2.7%) having PE diagnosed. No cases of missed PE were identified at 3 months. CONCLUSION: The introduction of the new guideline was associated with a reduction in overall imaging rates without evidence of missed PE. Further evaluation in other settings is recommended.
No takes yet. Share an insight, caveat, or question.
Banks et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: